Indication

Combined

1 clinical trial

1 product

Clinical trial

A Phase 4, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of Vaxelis™ in Healthy Children Previously Vaccinated With a 2-Dose Primary Infant Series of Either Vaxelis™ or Hexyon™

Status: Completed, Estimated PCD: 2022-08-30

Product